CoronaVac
South America
New Brazil data shows disappointing 50.4% efficacy for China’s CoronaVac vaccine
CND Team -
SAO PAULO, (Reuters) – A coronavirus vaccine developed by China’s Sinovac Biotech was just 50.4% effective at preventing symptomatic infections in a Brazilian trial,...